XTL Biopharmaceuticals Ltd. - ADR (XTLB) at a glance
XTL Biopharmaceuticals Ltd. - ADR (XTLB) is a micro-cap Healthcare company. It trades at $2.47, with a 0% profit margin and revenue growth of 78.4%. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Growth (92/100) and its weakest is Momentum (16/100). It is a relatively defensive holding with below-market volatility.
- Price
- $2.47
- Market cap
- $6.1M
- P/E ratio
- n/a
- Dividend yield
- None
- Beta
- 0.46
- 52-week range
- $2.01 to $10.28
Value
50
Growth
92
Income
40
Safety
90
Momentum
16
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,195.26-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$274.32+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$267.15-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$372.24-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$151.26-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.49+0.92%
2.16% yield
AMGN65
Amgen Inc.
$409.16-1.05%
2.76% yield